Lipid Mediators of Inflammation and Resolution in Individuals with Tuberculosis and Tuberculosis-Diabetes

Individuals with concurrent tuberculosis (TB) and Type 2 diabetes (DM) have a higher risk of adverse outcomes. To better understand potential immunological differences, we utilized a comprehensive panel to characterize pro-inflammatory and pro-resolving (i.e., mediators involved in the resolution of...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Prostaglandins Other Lipid Mediat
Autori principali: Shivakoti, Rupak, Dalli, Jesmond, Kadam, Dileep, Gaikwad, Sanjay, Barthwal, Madhusudan, Colas, Romain A., Mazzacuva, Francesca, Lokhande, Rahul, Dharmshale, Sujata, Bharadwaj, Renu, Kagal, Anju, Pradhan, Neeta, Deshmukh, Sona, Atre, Sachin, Sahasrabudhe, Tushar, Kakrani, Arjun, Kulkarni, Vandana, Raskar, Swapnil, Suryavanshi, Nishi, Chon, Sandy, Gupte, Akshay, Gupta, Amita, Gupte, Nikhil, Arriaga, María B., Fukutani, Kiyoshi F., Andrade, Bruno B., Golub, Jonathan E., Mave, Vidya
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2019
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7067657/
https://ncbi.nlm.nih.gov/pubmed/31726221
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.prostaglandins.2019.106398
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi